“Overview of Available Treatment and New Drug Action Points in Obesity Pharmacology. Will GIP, Glucagon, Amylin Replace GLP-1?”. Prospects in Pharmaceutical Sciences, vol. 23, no. 2, May 2025, pp. 42-49, https://doi.org/10.56782/pps.361.